June 20, 2025 Media Coverage from ARCH Venture Partners | Share ARCH’s Keith Crandell talks biotech investing with Axios Pro
May 27, 2025 Media Coverage from ARCH Venture Partners | Share ARCH’s Bob Nelsen appears on Forbes 2025 Midas List
April 10, 2025 Media Coverage from ARCH Venture Partners | Share ARCH Co-founder and Managing Director Bob Nelsen named to STAT’s 2025 STATUS list of the most influential people shaping the health industry
November 11, 2024 Press Releases from ARCH Venture Partners | Share ARCH Venture Partners Announces Promotion of Corey Ritter to Partner
October 12, 2024 Media Coverage from ARCH Venture Partners | Share Managing Director Kristina Burow named one of the top women in biopharma by Endpoints
September 27, 2024 Media Coverage from ARCH Venture Partners | Share Five ARCH-backed companies named to Endpoints 11 list of most exciting startups in 2024
September 26, 2024 Media Coverage from ARCH Venture Partners | Share ARCH Venture Partners raises $3 billion for a new biotech fund
September 26, 2024 Press Releases from ARCH Venture Partners | Share ARCH Venture Partners Announces New Fund to Create the Next Generation of Biotech Companies
April 23, 2024 Media Coverage from ARCH Venture Partners | Share With ARCH funding, Xaira Therapeutics aims to reinvent drug R&D by using artificial intelligence to deliver transformative medicines
April 18, 2024 Media Coverage from ARCH Venture Partners | Share ARCH-backed startup Metsera launches to develop drugs for obesity
April 9, 2024 Media Coverage from ARCH Venture Partners | Share ARCH funds neuropsychiatry company Seaport Therapeutics, led by the team behind Karuna Therapeutics
February 27, 2024 Media Coverage from ARCH Venture Partners | Share Managing Director Kristina Burow named to STAT’s 2024 STATUS list alongside other top leaders shaping the industry
